{"entity":{"type":"insider","cik":"0002095702","url":"/insider/0002095702","json_url":"/insider/0002095702.json","name":"Bulis Veronica Sanchez","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2025-11-12","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Bulis Veronica Sanchez","source":"filing","n_filings":5,"first_seen":"2025-11-12","last_seen":"2026-08-11"}],"transactions":[{"id":9297262,"accession":"0002095702-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002095702-26-000005","line_url":"/filing/0002095702-26-000005#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095702","owner_name":"Bulis Veronica Sanchez","owner_display_name":"Bulis Veronica Sanchez","owner_url":"/insider/0002095702","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":621.0,"shares_display":"621","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":8905.14,"total_display":"8,905.14","total_whole":"8,905","shares_owned_after":14799.0,"shares_owned_after_display":"14,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":5903314,"accession":"0002095702-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002095702-26-000004","line_url":"/filing/0002095702-26-000004#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095702","owner_name":"Bulis Veronica Sanchez","owner_display_name":"Bulis Veronica Sanchez","owner_url":"/insider/0002095702","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217.0,"shares_display":"217","price_per_share":18.91,"price_display":"18.91","price_state":"stated","total_value":4103.47,"total_display":"4,103.47","total_whole":"4,103","shares_owned_after":15420.0,"shares_owned_after_display":"15,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-06-15","scope":"insider"},{"id":6162415,"accession":"0002095702-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002095702-26-000002","line_url":"/filing/0002095702-26-000002#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095702","owner_name":"Bulis Veronica Sanchez","owner_display_name":"Bulis Veronica Sanchez","owner_url":"/insider/0002095702","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254.0,"shares_display":"254","price_per_share":23.12,"price_display":"23.12","price_state":"stated","total_value":5872.48,"total_display":"5,872.48","total_whole":"5,872","shares_owned_after":15637.0,"shares_owned_after_display":"15,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":5999258,"accession":"0002095702-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002095702-26-000001","line_url":"/filing/0002095702-26-000001#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095702","owner_name":"Bulis Veronica Sanchez","owner_display_name":"Bulis Veronica Sanchez","owner_url":"/insider/0002095702","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":32.32,"price_display":"32.32","price_state":"stated","total_value":30251.52,"total_display":"30,251.52","total_whole":"30,252","shares_owned_after":7141.0,"shares_owned_after_display":"7,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-06","scope":"insider"},{"id":5999256,"accession":"0002095702-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002095702-26-000001","line_url":"/filing/0002095702-26-000001#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095702","owner_name":"Bulis Veronica Sanchez","owner_display_name":"Bulis Veronica Sanchez","owner_url":"/insider/0002095702","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1136.0,"shares_display":"1,136","price_per_share":38.67,"price_display":"38.67","price_state":"stated","total_value":43929.12,"total_display":"43,929.12","total_whole":"43,929","shares_owned_after":8077.0,"shares_owned_after_display":"8,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2026-01-06","scope":"insider"},{"id":4936620,"accession":"0002095702-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002095702-25-000003","line_url":"/filing/0002095702-25-000003#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095702","owner_name":"Bulis Veronica Sanchez","owner_display_name":"Bulis Veronica Sanchez","owner_url":"/insider/0002095702","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":16.1,"price_display":"16.10","price_state":"stated","total_value":3847.9,"total_display":"3,847.90","total_whole":"3,848","shares_owned_after":9213.0,"shares_owned_after_display":"9,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806952","name":"Lyell Immunopharma, Inc.","url":"/issuer/0001806952","role":"Officer (VP, Corporate Controller)","n_filings":5,"first_seen":"2025-11-12","last_seen":"2026-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002095702","retrieved_at":"2026-08-22T15:07:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}